Ad is loading...
OPTN
Price
$0.43
Change
-$0.02 (-4.35%)
Updated
Nov 15 closing price
109 days until earnings call
SUPN
Price
$35.57
Change
-$0.61 (-1.69%)
Updated
Nov 15 closing price
107 days until earnings call
Ad is loading...

OPTN vs SUPN

Header iconOPTN vs SUPN Comparison
Open Charts OPTN vs SUPNBanner chart's image
OptiNose
Price$0.43
Change-$0.02 (-4.35%)
Volume$1.12M
CapitalizationN/A
Supernus Pharmaceuticals
Price$35.57
Change-$0.61 (-1.69%)
Volume$403.29K
CapitalizationN/A
OPTN vs SUPN Comparison Chart
Loading...
OPTN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
OPTN vs. SUPN commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPTN is a Sell and SUPN is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (OPTN: $0.44 vs. SUPN: $35.57)
Brand notoriety: OPTN and SUPN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: OPTN: 214% vs. SUPN: 102%
Market capitalization -- OPTN: $164.47M vs. SUPN: $1.84B
OPTN [@Pharmaceuticals: Other] is valued at $164.47M. SUPN’s [@Pharmaceuticals: Other] market capitalization is $1.84B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OPTN’s FA Score shows that 1 FA rating(s) are green whileSUPN’s FA Score has 0 green FA rating(s).

  • OPTN’s FA Score: 1 green, 4 red.
  • SUPN’s FA Score: 0 green, 5 red.
According to our system of comparison, SUPN is a better buy in the long-term than OPTN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OPTN’s TA Score shows that 4 TA indicator(s) are bullish while SUPN’s TA Score has 5 bullish TA indicator(s).

  • OPTN’s TA Score: 4 bullish, 5 bearish.
  • SUPN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SUPN is a better buy in the short-term than OPTN.

Price Growth

OPTN (@Pharmaceuticals: Other) experienced а -44.23% price change this week, while SUPN (@Pharmaceuticals: Other) price change was -2.81% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

OPTN is expected to report earnings on Mar 06, 2025.

SUPN is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SUPN($1.84B) has a higher market cap than OPTN($164M). SUPN YTD gains are higher at: 22.909 vs. OPTN (-66.279). SUPN has higher annual earnings (EBITDA): 90M vs. OPTN (-15.55M). SUPN has more cash in the bank: 255M vs. OPTN (73.7M). SUPN has less debt than OPTN: SUPN (41.5M) vs OPTN (132M). SUPN has higher revenues than OPTN: SUPN (608M) vs OPTN (71M).
OPTNSUPNOPTN / SUPN
Capitalization164M1.84B9%
EBITDA-15.55M90M-17%
Gain YTD-66.27922.909-289%
P/E RatioN/A1677.00-
Revenue71M608M12%
Total Cash73.7M255M29%
Total Debt132M41.5M318%
FUNDAMENTALS RATINGS
OPTN vs SUPN: Fundamental Ratings
OPTN
SUPN
OUTLOOK RATING
1..100
5031
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
79
Overvalued
PROFIT vs RISK RATING
1..100
10058
SMR RATING
1..100
10086
PRICE GROWTH RATING
1..100
9645
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OPTN's Valuation (31) in the Medical Or Nursing Services industry is somewhat better than the same rating for SUPN (79) in the Pharmaceuticals Other industry. This means that OPTN’s stock grew somewhat faster than SUPN’s over the last 12 months.

SUPN's Profit vs Risk Rating (58) in the Pharmaceuticals Other industry is somewhat better than the same rating for OPTN (100) in the Medical Or Nursing Services industry. This means that SUPN’s stock grew somewhat faster than OPTN’s over the last 12 months.

SUPN's SMR Rating (86) in the Pharmaceuticals Other industry is in the same range as OPTN (100) in the Medical Or Nursing Services industry. This means that SUPN’s stock grew similarly to OPTN’s over the last 12 months.

SUPN's Price Growth Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for OPTN (96) in the Medical Or Nursing Services industry. This means that SUPN’s stock grew somewhat faster than OPTN’s over the last 12 months.

SUPN's P/E Growth Rating (95) in the Pharmaceuticals Other industry is in the same range as OPTN (100) in the Medical Or Nursing Services industry. This means that SUPN’s stock grew similarly to OPTN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OPTNSUPN
RSI
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
71%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 6 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
71%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
69%
View a ticker or compare two or three
Ad is loading...
OPTN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSEQX61.33-0.59
-0.95%
JPMorgan Small Cap Equity R4
RPMMX18.59-0.23
-1.22%
Reinhart Mid Cap PMV Inv
LOAGX13.92-0.19
-1.35%
Lord Abbett International Growth F3
MSVYX19.51-0.27
-1.37%
MassMutual Small Cap Opps Svc
IYSIX22.59-0.38
-1.65%
Delaware Ivy Small Cap Growth Instl

OPTN and

Correlation & Price change

A.I.dvisor tells us that OPTN and RMTI have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPTN and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPTN
1D Price
Change %
OPTN100%
-4.40%
RMTI - OPTN
30%
Poorly correlated
-5.42%
PROC - OPTN
29%
Poorly correlated
-13.21%
AQST - OPTN
27%
Poorly correlated
-2.84%
INDV - OPTN
25%
Poorly correlated
-3.25%
SUPN - OPTN
24%
Poorly correlated
-1.69%
More

SUPN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SUPN has been loosely correlated with DVAX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if SUPN jumps, then DVAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
-1.69%
DVAX - SUPN
33%
Loosely correlated
-8.81%
PBH - SUPN
31%
Poorly correlated
-0.52%
AMRX - SUPN
29%
Poorly correlated
-5.89%
AQST - SUPN
29%
Poorly correlated
-2.84%
AMPH - SUPN
28%
Poorly correlated
-1.00%
More